Skip to content

Inspection prep notes · Data and records

Data integrity

Also called: ALCOA

FDA looks less at whether a data integrity policy exists than at who created a record, when, and whether it could be changed or deleted, checking this directly on instruments and documents. The findings below are quoted from warning letters and Form 483s.

What inspectors cited

1Electronic raw data could be deleted or modified

Specifically, electronic raw data used for release testing of batches (e.g., (b)(4) ) currently in the U.S. market was deleted and not accessible.

FDA Warning Letter · Outin Futures Corp. · 2024-10-15 · View document

For example, on November 21, 2025, your R&D personnel demonstrated that the raw data generated from confirmation testing stored in computer folder [redacted] can be potentially modified and deleted.

FDA 483 · Baxter Healthcare Corporation · 2026-10-30 · View document

2Laboratory instruments had no audit trail

For example, your ultraviolet-visible (UV-vis) and infrared (IR) spectroscopy equipment was found to lack audit-trail functionality, and your analysts were able to alter and delete data, files, and folders.

FDA Warning Letter · Guangxi Yulin Pharmaceutical Group Co. Ltd. · 2025-10-21 · View document

UV which uses software UV Probe 2.70 (equipment # QC/INST/13) does not have audit trail capabilities.

FDA 483 · Zen Chemicals Pvt. Ltd · 2026-10-19 · View document

3Records were pre-signed or backdated instead of made at the time of the work

Five blank preventative maintenance documents were discovered during the inspection that had been pre-signed and dated to January 9, 2025, in the “Performed by” section.

FDA Warning Letter · Tentamus India Private Limited · 2026-03-10 · View document

Your firm’s Deputy General Manager explained a procedural handling of documentation whereby the sterilization start time is not contemporaneously documented. Subsequently, a backdated sterilization start time was entered.

FDA 483 · Serum Institute of India Private Ltd. · 2026-10-26 · View document

4Original records and test evidence were discarded

However, your team leader had instructed staff to discard the bioburden plates with significant growth and had manipulated camera timestamps to create backdated documentation.

FDA Warning Letter · Huons Co., Ltd. · 2026-06-23 · View document

During our walkthrough of the QC laboratory on January 19, 2026, a discarded printout was found in a trash bin.

FDA 483 · Shimoga Chemicals · 2026-10-23 · View document

5User accounts and passwords were shared

The inspection documented that “System Administrator” was the only user type attributable in the (b)(4) Software and laboratory personnel shared a common password for the Windows and (b)(4) software systems.

FDA Warning Letter · Persōn & Covey, Inc. · 2025-09-30 · View document

Additionally, the pH meter does not have unique usernames and logins for individual operators. Instead, a shared username, "Analyst," is used by personnel.

FDA 483 · Fagron Analytical Services, LLC · 2026-10-26

Questions to check against your procedures

  1. Can an analyst with ordinary access delete or modify electronic raw data, files or folders? Has this been checked by demonstration?
  2. Can all electronic raw data used for release testing be retrieved today?
  3. Do standalone instruments such as UV, IR and pH meters also have an audit trail?
  4. Are there blank forms already signed and dated, or records dated back after the work? Are entries such as start times made at the moment of the work?
  5. Are printouts found in laboratory trash bins? Are printouts and plates from duplicate or failing tests also kept as records?
  6. Does each instrument have a unique account for each operator? Is testing ever done under a shared username, a shared password or an administrator account?

Compiled by AI from public findings and checked by a person. Quotations are verbatim from the original documents; (b)(4) marks text redacted in the original. As of 2026-11-15.

Weekly Newsletter

New GMP inspection findings, every Monday

Every Monday we email the week's new inspection records from the FDA, EMA, Health Canada and MFDS, with a short summary of the week's regulatory news. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.